Sharon M. Castellino
@SharonCastelli2
Followers
307
Following
1K
Media
15
Statuses
288
Director, Pediatric Leukemia/Lymphoma @ATL peds; Professor@EmoryMed; Lymphoma; Survivorship/Outcomes; Reducing Disparities; #WomenInMedicine. Views are my own.
Atlanta, GA
Joined September 2016
What happens when patient advocates, healthcare leaders, and AI innovators unite? Magic, and a healthy discussion that drives real innovation. At our Patient Advocacy AI Innovation Lab at #ASH2025, 60% of attendees already use AI tools in their work, yet 54% worry about
0
4
9
Interested in learning about the latest topics in pediatric hematology? Our team will be attending and presenting on a variety of topics at @ASH_hematology's 67th Annual Meeting and Exposition, from December 6-9 in Orlando. Learn more: https://t.co/BlwILGIETT.
#ASH25
0
1
2
Our @JNCI_Now study shows that receiving survivorship care plan, embedded in a comprehensive survivorship program, is associated with improved survival among childhood cancer survivors. @SharonCastelli2 @DrEffinger @JordanGMarchak @WinshipAtEmory @ATLPedsHemOnc @EmoryPediatrics
A new study led by researchers at Winship and @childrensatl shows that childhood cancer survivors who engage in long-term survivorship programs and receive a personalized survivorship care plan live longer than those who do not. Read more ➡️ https://t.co/boaSbip7JR
0
1
4
At @BloodCancerUtd, we're all about the Accelerating Kids' Access to Care Act, so kids with cancer can be about everything else. Watch to learn more about the bill and how it can help kids with cancer ⬇️
0
1
5
Nivolumab-AVD Versus Brentuximab Vedotin–AVD in Older Patients With Advanced-Stage Classic Hodgkin Lymphoma Enrolled on S1826 | Journal of Clinical Oncology
ascopubs.org
Older patients with classic Hodgkin lymphoma (cHL) have inferior survival compared with younger patients. We report a subset analysis of older patients (60 years and older) enrolled in the phase...
0
35
98
Kids with cancer deserve a chance to thrive. But in December, Congress missed a key opportunity to extend programs that incentivize drug companies to find them cures. Learn more about the Give Kids a Chance Act, and how it can help children with cancer ⬇️ https://t.co/BzCmTV1nqS
statnews.com
In Washington, even widely hailed programs with bipartisan support — like the rare pediatric disease priority review voucher program — are falling by the wayside, writes BridgeBio’s Neil Kumar.
0
2
6
#AACR25 Honored to co-chair (with Mimi Bondopadhayay) great science - mini symposium on #Pediatric Advances_Bench to Bedside.
0
0
9
Check out the latest findings from @NavigatorSurvey, which found that an overwhelming number of Americans want the healthcare tax credit extended and would back members of Congress who do so ⬇️ https://t.co/QzPi98QR0i
#NoHealthcareCuts
0
4
4
Members of Congress are now back in their home districts for a 2-week spring recess. Check the websites of your Senators and Rep to find out if there are events happening near you that might give you the chance to speak up about #ChildhoodCancer issues like NCI funding.
1
2
1
The #COGF Newsletter - Spring 2025 is here! This edition covers the road from idea to clinical trial, a foundations philanthropic support for kidney cancer research, an interview w/ Renal Chair, Nicholas Cost, & a letter from our Group Chair, Doug Hawkins.
0
2
4
Some in Congress are rushing to cut $880B from #Medicaid. These cuts will terminate healthcare for 10M people, including blood cancer patients. Without coverage, many will not be able to afford care. Tell your Senator to oppose Medicaid cuts ⬇️ https://t.co/SzowXyyheI
0
4
10
ASH and 90+ Organizations Call for HHS to Immediately Restore CDC’s Division of Blood Disorders. Without it, patients with blood diseases face preventable risks. ASH is calling for its restoration. 🔗 https://t.co/fgdAmtttDb
#Fight4Hematology
0
6
12
Working to support #AYA patients from diagnosis through survivorship @ATLPedsHemOnc with treatment, supportive care and policy advocacy
In honor of #AYACancerAwarenessWeek, we want to recognize our AYA patients and the dedicated staff who are working to make tremendous strides to bridge the gap from patient diagnosis to survivorship.
0
0
7
ASH decries HHS restructuring and CDC layoffs. The Blood Disorders Division addresses SCD, thrombosis, hemophilia, thalassemia, and more. Millions' health is at stake; ASH urges immediate action. #Fight4Hematology
1
13
17
It's #AYACancerWeek. Did you know that lymphoma is responsible for nearly 1 in 5 cancer diagnoses in young people? This week, we'll share stories from AYA patients, resources designed uniquely for them, & updates on how we're supporting the AYA community: https://t.co/kt5Ru2qvg2
0
4
3
We are so excited to share that the DoD CDMRP has allocated $75 M to fund 34 research awards for cancers affecting children, adolescents and young adults as part of the FY24 budget. Your voice matters. 💛 #ChildhoodCancer #RallyOn
0
2
5
Nothing will kill more children than the ongoing decimation of CDC, NIH, and USAID work to lift vaccine uptake in the US and world. Child survival rose 75% in the last 50 years. Vaccines account for 40% of that. Measles vax alone was 60% of the benefit.
thelancet.com
Since 1974 substantial gains in childhood survival have occurred in every global region. We estimate that EPI has provided the single greatest contribution to improved infant survival over the past...
199
2K
4K
In countries with weak safety nets like China, people hoard cash for medical emergencies—saving 30-35% of income vs. our 7-8%. This means less spending at YOUR business, fewer customers at YOUR restaurant, slower growth in YOUR community. #EconomyThrives
1
1
0
“We are deeply disappointed that Congress approved steep cuts to cancer research that for many years has generated groundbreaking FDA-approved treatments for adult & pediatric blood cancer patients. LLS will continue to fight for federal investments in lifesaving research.”
2
8
14